| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90e58d7dc32cf6ba94fd42e891f6bb36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19a04ecc8c4ed6b0a2e92cdb237fe7f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f04353213bc5bffcb9aa6a8be16eaf68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9f4ec8fc436cb0bcf6e2f6e567c1df7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1897c2364b0893589b89bdf9cc2d5f98 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00228f4f5cb2fd15cee4a06d0a04ea83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_780f66db54687f3f3583d88ade0a7e19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3daafbfc98ef56e498f838be9ace72c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d05197ce220bdead9797ea595551d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d272777c9005225a9399cd24607445a |
| publicationDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0185930-A9 |
| titleOfInvention |
Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| abstract |
This invention relates to methods and agonist/antagonist compounds for modulating melanocortin receptor-ligand binding. Also included is a method of identifying agonists and/or antagonists that bind to a ligand binding site for a melanocortin receptor of interest. Agonists and antagonists of ligand binding to melanocortin receptors also are provided. The invention is exemplified by identification and manipulation of the C-terminus of the human agouti related protein, which binds melanocortin receptors 3 and 4, and the prodution of AGRP peptidomimetics that are melanocortin receptor ligands. The methods can be applied to other melanocortin receptor agonists and antagonists. |
| priorityDate |
2000-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |